RHOEN-KLINIKUM AG header image

RHOEN-KLINIKUM AG

RHK

Equity

ISIN DE0007042301 / Valor 341644

Xetra (2025-10-21)
EUR 11.70-0.85%

RHOEN-KLINIKUM AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

RHOEN-KLINIKUM AG is a German healthcare company that operates hospitals and medical facilities, providing a range of medical services to patients.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (17.10.2025):

In the first quarter of 2024, RHÖN-KLINIKUM AG demonstrated robust financial performance, with significant increases in revenues and profits compared to the same period in the previous year. The company appears well-positioned to navigate the ongoing hospital reform and market challenges.

Revenue Growth

Revenues rose by €21.3 million, a 5.9% increase, reaching €382.8 million in Q1 2024 compared to €361.5 million in Q1 2023. This growth was driven by a 2.6% increase in patient numbers and higher state base rates.

Profitability Enhancements

Consolidated profit surged by €4.7 million, marking a 73.4% increase to €11.1 million. EBITDA rose by €2.7 million (12.0%) to €25.2 million, while EBIT saw an impressive increase of €3.8 million (61.3%) to €10.0 million.

Cost Management

Material expenses grew by €11.7 million (9.8%) due to rising purchase prices, slightly outpacing revenue growth. Employee benefits also increased by €18.0 million (7.5%) driven by higher wages and a growing workforce, resulting in a personnel expense ratio adjustment from 66.1% to 67.2%.

Financial Position

The company's net assets saw a modest increase, with total assets rising to €1,811.6 million from €1,770.5 million at the end of December 2023. Shareholders' equity grew to €1,291.7 million, reflecting the strong financial performance in the quarter.

Summarized from source with an LLMView Source

Key figures

-7.14%1Y
-20.1%3Y
-28.9%5Y

Performance

34.7%1Y
33.3%3Y
30.0%5Y

Volatility

Market cap

907 M

Market cap (USD)

Daily traded volume (Shares)

500

Daily traded volume (Shares)

1 day high/low

13.9 / 13.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%DKK 240.80
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.38%USD 15.20
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%CHF 88.54
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.70%CHF 227.10
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%CHF 311.00
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%CHF 13.10
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%CHF 24.05
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%CHF 81.50
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.33%CHF 9.25
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%CHF 48.65